Tirzepatide, semaglutide, and liraglutide lead to weight loss in adults with obesity and T1D over 1 year; the greatest weight ...

Popular weight loss shots carry significant risk for some patients and doctors often fail to discuss those risks with ...

GLP-1 RAs, particularly semaglutide and tirzepatide, outperform older medications in achieving significant weight loss in adults with and without type 2 diabetes. Semaglutide and tirzepatide met ...

Scientists are uncovering how GLP-1 drugs like Ozempic and Wegovy act on brain regions that control hunger, nausea, pleasure-based eating, and thirst. These discoveries may help create treatments that ...

In the first quarter of 2018, there were less than five postpartum GLP-1 prescriptions, but by the second quarter of 2022, the number rose to 34 per 10,000 and sharply increased to 173 per 10,000 in ...

JOANNA had struggled with her weight for years – but despite trying her hardest to shed the excess pounds, she’d quickly pile ...

Daily Mail recently checked into Clinton Hall in Midtown Manhattan, to try its Teeny Weeny Mini Meal designed for those with ...

A WEIGHT loss pill set to be available next year will be a cheaper, easier and effective alternative to Mounjaro injections, ...

Studies from Novo Nordisk due early next month will give the strongest indication yet of whether blockbuster GLP-1 drugs - a ...

The recommended discontinuation of GLP-1 receptor agonists during pregnancy was associated with more gestational weight gain ...

An oral version of semaglutide, the active ingredient in blockbuster drugs Ozempic and Wegovy, failed to slow the progression ...

Public interest in drugs known as glucagon-like peptide-1 receptor agonists, also called GLP-1 RAs, has surged in recent ...